Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 19]
Recall of Viracept (Nelfinavir)
Friday, 8 June 2007, 5:03 pm | PHARMAC
Pharmaceutical company Roche is taking responsible action with its voluntary recall of the anti-HIV treatment nelfinavir (Viracept), says government drug-funding agency PHARMAC. More >>
$21m savings for migraine medicines
Thursday, 24 May 2007, 2:17 pm | PHARMAC
People needing relief for migraine attacks will have a choice of fully funded treatments as a result of a new move by PHARMAC that will also save more than $20 million. More >>
Building a culture of medicine safety
Thursday, 17 May 2007, 9:30 am | PHARMAC
A culture of safety around medicines and reducing medication errors are two of the key themes for a two-day workshop in Wellington this week. More >>
350 women each year benefit on Herceptin decision
Thursday, 3 May 2007, 10:38 am | PHARMAC
About 350 women are set to benefit each year from the decision to fund Herceptin for early HER2-positive breast cancer. Funding will be available from 1 July this year in a move that represents an investment of $6 million per year by District Health ... More >>
Further step in battle with Type 2 diabetes
Friday, 30 March 2007, 11:39 am | PHARMAC
PHARMAC is giving more people the chance to access the Type 2 diabetes medicine pioglitazone (Actos). The medicine funding decision is PHARMAC’s latest contribution to combating type 2 diabetes. In addition to funding medicines, PHARMAC has also worked with Diabetes ... More >>
PHARMAC asking for views on Herceptin funding
Tuesday, 20 March 2007, 11:11 am | PHARMAC
Breast cancer drug Herceptin is a step closer to being more accessible for NZ women, with PHARMAC today seeking feedback on a proposal to fund a 9 week treatment option for women with HER2-positive early breast cancer. More >>
Two new medicines funded for people with HIV
Thursday, 15 March 2007, 2:16 pm | PHARMAC
Tenofovir (Viread) and emtricitabine (Emtriva) are comparatively new treatments that have similar actions to anti-HIV medicines that are already funded. However, they have some advantages over already-funded medicines and are important because the ... More >>
Significant Doubts Remain Over 12-Month Treatment
Friday, 16 February 2007, 4:42 pm | PHARMAC
Not all evidence related to Herceptin has been published and New Zealanders need to be aware of that. More >>
Pharmacology Advisory Committee Meeting
Friday, 16 February 2007, 9:43 am | PHARMAC
24.5.1 PTAC noted and accepted the minutes of the Cancer Treatments Sub-Committee of PTAC (CaTSoP) meeting held on 26 / 27 October 2006, with the following comments: More >>
Pharmac Supporting International Trial
Friday, 16 February 2007, 9:42 am | PHARMAC
PHARMAC has announced its financial support for an international trial that will further examine whether 9 weeks or 12 months is the better treatment option for Herceptin. More >>
PHARMAC Welcomes Fresh Supply Of Adrenaline For NZ
Wednesday, 24 January 2007, 2:19 pm | PHARMAC
Government drug funding agency PHARMAC is pleased that pharmaceutical company AstraZeneca has secured a supply of adrenaline for New Zealanders. More >>
PHARMAC doing all it can regarding adrenaline
Friday, 19 January 2007, 4:36 pm | PHARMAC
PHARMAC is doing all it can to help with continued supply of emergency drug adrenaline. These comments follow claims by the New Zealand Medical Association about concerns over adrenalin supply resulting from a manufacturing problem of a major international ... More >>
Herceptin: PHARMAC assures NZers of robust process
Friday, 19 January 2007, 3:00 pm | PHARMAC
PHARMAC is continuing to follow its processes around considering funding of breast cancer drug Herceptin - and no further decision has been made. More >>
Patients get easier access to antidepressant
Thursday, 18 January 2007, 12:21 am | PHARMAC
Patients will have easier access to a widely used antidepressant, following a PHARMAC decision to fund the generic form of paroxetine. More >>
PHARMAC seeks best deal for NZers through tender
Monday, 15 January 2007, 9:39 am | PHARMAC
PHARMAC is continuing to secure the best possible value for the health dollar with the release of the latest tender round. The Government drug funding agency is tendering for supply of 249 different medicines used in both hospitals and the community. More >>
More Treatment Options For People With Bipolar
Tuesday, 9 January 2007, 2:20 pm | PHARMAC
People with bipolar disorder will benefit from a PHARMAC decision to widen access to a medicine already used to treat epilepsy. More >>
Four into one for new HIV TREATMENT
Thursday, 21 December 2006, 12:05 am | PHARMAC
People taking four tablets a day for HIV will soon only need to take one, following a funding decision by PHARMAC More >>
PHARMAC seeking feedback on High Cost Medicines
Monday, 18 December 2006, 2:23 pm | PHARMAC
PHARMAC is seeking public submissions on a review of how high cost medicines are assessed and funded. More >>
Making best use of medicines a key challenge
Tuesday, 28 November 2006, 4:20 pm | PHARMAC
PHARMAC is giving New Zealanders a “could do better” for the way they use medicine. Figures released in PHARMAC’s 2006 Annual Review show that prescriptions for subsidised medicine have reached an all-time high of 28.5 million prescriptions, independent ... More >>
Improving health literacy key to improving health
Tuesday, 28 November 2006, 1:34 pm | PHARMAC
There are few things more powerful than a well-informed patient, and an improvement in `health literacy’ is likely to significantly improve health results for New Zealanders, says PHARMAC’s Medical Director Dr Peter Moodie. More >>
